Mazumdar Claire Insider Trading Activity
Mazumdar Claire has been net-selling over the last 12 months with 0 purchases and 16 sales across 1 company.
BCAX is the most-traded position with 16 trades. The largest single transaction was a sale of BCAX for $776K on Nov 24, 2025.
Performance Scorecard
Forward stock performance after each transaction by Mazumdar Claire. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.9% | 36% | 14 |
| 90 days | — | -6.3% | 33% | 12 |
| 120 days | — | -26.2% | 36% | 11 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBCAX · Bicara Therapeutics Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Mazumdar Claire bought and sold BCAX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 10, 2026 | BCAX | Sell | 28 | $29.68 | $831.04 | −0.0% | CEO | |
Jul 10, 2026 | BCAX | Sell | 9,972 | $28.42 | $283K | −2.7% | CEO | |
May 18, 2026 | BCAX | Sell | 12,022 | $19.96 | $240K | −3.2% | CEO | |
May 18, 2026 | BCAX | Sell | 2,978 | $20.35 | $61K | −0.8% | CEO | |
Apr 20, 2026 | BCAX | Sell | 15,000 | $23.61 | $354K | −4.0% | CEO | |
Mar 20, 2026 | BCAX | Sell | 1,596 | $18.95 | $30K | −0.5% | CEO | |
Mar 19, 2026 | BCAX | Sell | 6,905 | $18.78 | $130K | −2.0% | CEO | |
Mar 18, 2026 | BCAX | Sell | 6,499 | $18.84 | $122K | −1.9% | CEO | |
Mar 9, 2026 | BCAX | Sell | 36,766 | $19.17 | $705K | −9.8% | CEO | |
Mar 6, 2026 | BCAX | Sell | 3,817 | $18.75 | $72K | −1.1% | CEO | |
Mar 5, 2026 | BCAX | Sell | 1,786 | $18.74 | $33K | −0.5% | CEO | |
Mar 4, 2026 | BCAX | Sell | 2,631 | $18.73 | $49K | −0.8% | CEO | |
Nov 24, 2025 | BCAX | Sell | 41,163 | $18.86 | $776K | −11.7% | CEO | |
Oct 16, 2025 | BCAX | Sell | 24,103 | $18.83 | $454K | −7.2% | CEO | |
Oct 15, 2025 | BCAX | Sell | 13,289 | $18.84 | $250K | −4.1% | CEO | |
Oct 13, 2025 | BCAX | Sell | 11,445 | $18.92 | $217K | −3.6% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 16 | $3.8M |
Other insiders at Bicara Therapeutics Inc.
4 other tracked filers at BCAX.